Fazeli Bahare, Ravari Hassan
Inflammation and Inflammatory Diseases Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Curr Med Chem. 2015;22(16):1992-2001. doi: 10.2174/0929867322666150429112111.
Thromboangiitis obliterans (TAO) is a thrombotic-occlusive and an inflammatory peripheral arterial disease with unidentified aetiology. Thrombotic events can lead to limb loss in TAO patients, who are typically young male smokers of low socioeconomic status. It is still unknown whether the initial process is thrombosis or inflammation, so it is difficult to ascertain whether managing inflammation or thrombosis improves the outcome of the disease. In this review, the possible mechanisms of thrombosis in TAO are evaluated; the treatments, based on the discussed mechanisms of thrombosis in TAO, are then reviewed and the challenges and limitations associated with the management of TAO are discussed.
血栓闭塞性脉管炎(TAO)是一种血栓闭塞性和炎症性外周动脉疾病,病因不明。血栓形成事件可导致TAO患者肢体丧失,这类患者通常是社会经济地位较低的年轻男性吸烟者。目前尚不清楚初始过程是血栓形成还是炎症,因此难以确定治疗炎症还是血栓形成能改善疾病结局。在本综述中,评估了TAO中血栓形成的可能机制;然后根据所讨论的TAO血栓形成机制回顾了治疗方法,并讨论了TAO管理相关的挑战和局限性。